We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+19.36%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.31B
AUM Growth
-$137M
Cap. Flow
-$269M
Cap. Flow %
-20.53%
Top 10 Hldgs %
64.88%
Holding
54
New
1
Increased
4
Reduced
9
Closed
10

Top Buys

Rank Stock Value
1
PHAT icon
Phathom Pharmaceuticals
PHAT
+$14.7M
2
XFOR icon
X4 Pharmaceuticals
XFOR
+$5.57M
3
BDTX icon
Black Diamond Therapeutics
BDTX
+$2.04M
4
RGLS
Regulus Therapeutics
RGLS
+$667K
5
DM
Desktop Metal, Inc.
DM
+$17.4K

Top Sells

Rank Stock Value
1
IONQ icon
IonQ
IONQ
+$89.9M
2
NET icon
Cloudflare
NET
+$77M
3
MIRM icon
Mirum Pharmaceuticals
MIRM
+$53.2M
4
ACLX
Arcellx
ACLX
+$38.2M
5
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$15.5M

Sector Composition

Rank Sector Weight
1 Healthcare 76.63%
2 Consumer Staples 12.79%
3 Industrials 7.44%
4 Technology 2.55%
5 Communication Services 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSBR icon
26
Champions Oncology
CSBR
$73.6M
$10.9M 0.83%
1,713,720
– –
TUYA
27
Tuya Inc
TUYA
$1.07B
$9.33M 0.71%
4,934,640
– –
UTRS
28
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$8.82M 0.67%
1,721,853
– –
CBIO
29
Crescent Biopharma
CBIO
$586M
$8.29M 0.63%
47,644
– –
NKTX icon
30
Nkarta
NKTX
$157M
$7.82M 0.6%
3,568,781
– –
BZFD icon
31
BuzzFeed
BZFD
$92.4M
$7.74M 0.59%
3,833,473
– –
ACRV icon
32
Acrivon Therapeutics
ACRV
$70.2M
$6.24M 0.48%
481,677
– –
IVA
33
Inventiva
IVA
$1.12B
$5.91M 0.45%
1,462,586
– –
LXRX icon
34
Lexicon Pharmaceuticals
LXRX
$1.09B
$5.46M 0.42%
2,382,286
– –
GOSS icon
35
Gossamer Bio
GOSS
$86.9M
$4.16M 0.32%
3,467,406
– –
MRKR icon
36
Marker Therapeutics
MRKR
$19M
$3.32M 0.25%
1,071,428
– –
RGLS
37
DELISTED
Regulus Therapeutics
RGLS
$2.86M 0.22%
1,945,579
+500,465
+35% +$667K
SNTI icon
38
Senti Biosciences Holdings
SNTI
$11.6M
$2.78M 0.21%
442,615
-27,424
-6% -$268K
AFMD
39
DELISTED
Affimed
AFMD
$2.65M 0.2%
442,649
– –
SYBX
40
DELISTED
Synlogic
SYBX
$1.82M 0.14%
281,929
– –
EAR
41
DELISTED
Eargo, Inc. Common Stock
EAR
$1.02M 0.08%
207,886
-18,114
-8% -$91.7K
ADXN
42
Addex Therapeutics
ADXN
$7.2M
$633K 0.05%
9,000
-273,435
-97% -$3.97M
UP icon
43
Wheels Up
UP
$208M
$124K 0.01%
5,306
-236
-4% -$16.7K
AKTX
44
Akari Therapeutics
AKTX
$13.1M
$76.9K 0.01%
565
– –
IONQ icon
45
IonQ
IONQ
$14.9B
– –
-14,614,829
Closed -$89.9M
NET icon
46
Cloudflare
NET
$104B
– –
-1,249,215
Closed -$77M
NOTE
47
DELISTED
FiscalNote
NOTE
– –
-25,612
Closed -$576K
PANW icon
48
Palo Alto Networks
PANW
$296B
– –
-156
Closed -$15.6K
MIMO
49
DELISTED
Airspan Networks Holdings Inc
MIMO
– –
-1,359,842
Closed -$941K
MIMO.WS.B
50
DELISTED
Airspan Networks Holdings Inc Warrants
MIMO.WS.B
– –
-69,928
Closed -$30
1
2
3

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
GD
Grandfield & Dodd New York $1.77B AUM 23.43% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return

NEA Management Company's Q2 2023 Portfolio in Review

As of Q2 2023, NEA Management Company held 54 positions worth $1.31B, down 9.4% from $1.45B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

NEA Management Company withdrew a net $269M in Q2 2023, closing 10 positions and reducing 9 holdings. Its most notable exit was IonQ, an estimated $89.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 67% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, NEA Management Company opened a new position in Phathom Pharmaceuticals worth $18.3M.

  • NEA Management Company's largest Q2 2023 buy was Phathom Pharmaceuticals: 1,276,595 shares worth $18.3M.
  • NEA Management Company added most to X4 Pharmaceuticals in Q2 2023, an estimated $5.57M increase.
  • NEA Management Company's biggest Q2 2023 reduction was Mirum Pharmaceuticals, cutting an estimated $53.2M.
  • NEA Management Company fully exited IonQ in Q2 2023, selling an estimated $89.9M.
  • NEA Management Company's ten largest holdings make up 65% of its $1.31B portfolio in Q2 2023.
  • NEA Management Company opened 1 new position and closed 10 in Q2 2023.
  • NEA Management Company's portfolio value fell 9.4% quarter-over-quarter to $1.31B.

Based on NEA Management Company's 13F filing for Q2 2023, filed 11 Aug 2023.